Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin PBPK Modeling in Healthy Volunteers (IVMPBPK)
NCT02963324Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Nov 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ivermectin in malaria, sponsored by University Hospital Basel. Primary endpoints: Maximum concentration at 72 hours, Time to maximum concentration at 72 hours and 1 more. Started Nov 2016; status: completed.
02
Drugs
ivermectin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02963324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02963324.